Securities code: Bloomage Biotechnology Corporation Limited(688363) securities abbreviation: Bloomage Biotechnology Corporation Limited(688363) Announcement No.: 2022008 Bloomage Biotechnology Corporation Limited(688363)
Special report on the deposit and actual use of raised funds in 2021
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear legal responsibility for the authenticity, accuracy and integrity of its contents according to law. 1、 Basic information of raised funds (I) actual amount of raised funds and time of funds in place
With the approval of Shanghai Stock Exchange and the approval of CSRC zjxk (2019) No. 1796 on the approval of Bloomage Biotechnology Corporation Limited(688363) IPO registration, Huatai United Securities Co., Ltd., the lead underwriter of the company, adopts directional placement to strategic investors through the system of Shanghai Stock Exchange 49562556 ordinary shares (A shares) in RMB were publicly issued by the combination of offline inquiry and placement to qualified investors and online pricing issuance to social public investors holding non restricted A-Shares or the market value of non restricted depositary receipts in Shanghai market, with a par value of 1 yuan per share and an issuance price of 47.79 yuan / share, increasing the share capital of 49562556 shares.
The total amount of funds raised by the company is 236859455124 yuan. After deducting the underwriting fee and recommendation fee of 926 Shanghai Pudong Development Bank Co.Ltd(600000) 0 yuan, the actual amount of funds raised by the company on October 30, 2019 is 227593455124 yuan. After deducting the recommendation fee, audit evaluation and capital verification fee, lawyer fee and other fees related to the issuance of 2698012624 yuan, The net amount of raised funds is 224895442500 yuan.
The above net amount of raised funds has been verified in the capital verification report (ztyz (2019) No. 110zc0182) of Grant Thornton Certified Public Accountants (special general partnership). （2） Use and balance of raised funds
1. Balance of raised funds as of December 31, 2021
(1) Balance of raised funds
Project amount (yuan)
As of December 31, 2020, the balance of actually raised funds was 152037497358
Less: the total amount of projects directly invested by raising funds in 2021 is 72113524143
Less: service charge expenditure in 2021: 681252
Plus: interest and wealth management income in 20212651025890
Balance on December 31, 2021: 82574317853
(2) Use of raised funds
① As of December 31, 2020, the company has invested 78077678800 yuan in projects invested by raising funds, 72113524143 yuan in 2021, and 150191202943 yuan in projects invested by raising funds as of December 31, 2021.
② As of December 31, 2021, the balance of the raised funds account is 82574317853 yuan, including 19299317853 yuan of bank deposit, 20000000000 yuan of seven-day notice deposit, 17000000000 yuan of negotiable certificate of deposit, 20000000000 yuan of Huatai Securities Co.Ltd(601688) brokerage income certificate and 6275000000 yuan of international letter of credit deposit. 2、 Deposit and management of raised funds (I) management of raised funds
In order to standardize the management and use of raised funds and protect the rights and interests of investors, the company has formulated the Bloomage Biotechnology Corporation Limited(688363) raised funds management system (hereinafter referred to as the “management measures”) in accordance with laws and regulations and in combination with the actual situation of the company, which clearly stipulates the storage, use, purpose change, management and supervision of the special account for raised funds.
According to the management measures and in combination with the business needs, the company and its subsidiaries implementing the investment project of raised funds have signed the supervision agreement of the special account of raised funds with the sponsor and the special account supervision Bank of raised funds in October 2019 and March 2021 to strictly approve the use of raised funds, so as to ensure the special use of funds. There is no significant difference between the aforesaid agreement and the tripartite supervision agreement (model) on the storage of special account for raised funds of Shanghai Stock Exchange. As of December 31, 2021, the company has deposited and used the raised funds in strict accordance with the provisions of the regulatory agreement.
（2） Storage of raised funds in special account
As of December 31, 2021, the specific deposit of the special account for raised funds is as follows:
Unit: RMB
Deposit bank account number account category storage balance
Beijing Rural Commercial Bank
Bank of China Co., Ltd. 1803 China Baoan Group Co.Ltd(000009) 210 special deposit account 24290500 Jianguomen sub branch bank of Dalian Co., Ltd
Limited company Beijing Fengtai 11512600 China Baoan Group Co.Ltd(000009) 6 special deposit account 12840546136 sub branch
Bank Of Beijing Co.Ltd(601169) Dongchang’an 2 Shenzhen Guohua Network Security Technology Co.Ltd(000004) 1791400030773476 special deposit account 20557834496th Street sub branch
China Merchants Bank Co.Ltd(600036) shares have 531902278110905 special deposit account 22876646721 limited company Jinan Branch
Total 56299317853
Note: 1. In addition to the funds deposited in the special account for raised funds, another 6275000000 yuan is deposited in the L / C margin account associated with the raised funds account opened by China Merchants Bank Co.Ltd(600036) Jinan Branch for the opening of international L / C of raised investment projects; There is 20000000000 yuan transferred out for the purchase of Huatai Securities Co.Ltd(601688) brokerage income certificate.
2. Among the above deposit balances, RMB 2651025890 has been included in the interest and financial management income of the special account for raised funds in 2021, and RMB 681252 has been deducted from the service charge in 2021.
3、 Actual use of raised funds in 2021 (I) use of funds for raised investment projects
See attached table 1: comparison table of the use of raised funds for the actual use of raised funds in 2021. （2） Advance investment and replacement of raised investment projects
On April 28, 2020, the company held the 14th meeting of the first board of directors and the 9th meeting of the first board of supervisors, deliberated and approved the proposal on replacing the self raised funds invested in advance with the raised funds respectively, and agreed to use the raised funds of 951963 million yuan to replace the self raised funds invested in the investment projects invested in advance with the raised funds. According to the verification report on Bloomage Biotechnology Corporation Limited(688363) pre investment of raised funds in projects with self raised funds (ztzz (2020) No. 110za4095) issued by Zhitong Certified Public Accountants (special general partnership) on April 28, 2020, as of March 31, 2020, The actual investment of the company’s self raised fund is RMB 956300. At present, the company has used the raised funds to replace the self raised funds invested in the raised investment projects of RMB 951963 million.
（3） Temporary replenishment of working capital with idle raised funds
As of December 31, 2021, the company does not temporarily supplement working capital with idle raised funds.
（4） Cash management of idle raised funds and investment in related products
On December 8, 2021, the company held the 28th meeting of the first board of directors and the 23rd Meeting of the first board of supervisors, deliberated and adopted the proposal on continuing to use idle raised funds for cash management, and agreed that the company would not affect the construction of investment projects and the use arrangement of raised funds, and effectively control risks, Within 12 months from the date of deliberation and approval by the board of directors, the temporarily idle raised funds up to RMB 700 million shall be subject to cash management, and the principal guaranteed investment products sold by financial institutions with high safety, good liquidity and legal business qualification shall be purchased. The amount of RMB 700 million can be recycled and rolled.
As of December 31, 2021, the total amount of negotiable certificates of deposit and securities firm income certificates that have not been redeemed by the company is 57000000000 yuan. The details are as follows:
Unit: RMB
The period from the beginning to the end of the estimated annualized 2021 product name amount of the partner’s product category
Nominal yield status as of December 31
Bank Of Beijing Co.Ltd(601169) call deposit 2000000000 flexible term 2.025% being fulfilled
Bank Of Beijing Co.Ltd(601169) call deposit 2000000000 flexible term 2.025% being fulfilled
Bank Of Beijing Co.Ltd(601169) call deposit 1000000000 flexible term 2.10% being fulfilled
Bank Of Beijing Co.Ltd(601169) call deposit 5000000000 flexible term 2.10% being fulfilled
Bank Of Beijing Co.Ltd(601169) call deposit 10000000000 flexible term 2.10% being fulfilled
Transferable big 2021 / 6 / 2-
China Merchants Bank Co.Ltd(600036) deposit 2000000000 3.81% under performance certificate of deposit 2022 / 3 / 18
China Merchants Bank Co.Ltd(600036) transferable large deposit 60000 China Vanke Co.Ltd(000002) 021 / 7 / 2 – 3.43% is being fulfilled
Certificate of deposit 2022 / 6 / 12
Transferable big 2021 / 7 / 1-
China Merchants Bank Co.Ltd(600036) deposit 1000000000 3.60% under performance certificate of deposit 2022 / 4 / 16
Transferable big 2021 / 8 / 19-
China Merchants Bank Co.Ltd(600036) deposit 3000000000 3.30% under performance certificate of deposit 2022 / 6 / 25
Transferable big 2021 / 12 / 10-
China Merchants Bank Co.Ltd(600036) deposit 1000000000 3.30% under performance certificate of deposit 2023 / 11 / 19
Transferable big 2021 / 12 / 15-
China Merchants Bank Co.Ltd(600036) deposit 1000000000 3.36% under performance certificate of deposit 2024 / 2 / 9
Transferable large
